PapersOthers（Reference ducuments）Limited proteolysis Koguchi et al.(2021) [nSMOL] Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab J Immunother Cancer 2021;9:e002663 論文・技術情報一覧に戻る
PAGE TOP